MedPath

SANOFI-AVENTIS FRANCE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

19

Active:16
Completed:2

Trial Phases

3 Phases

Phase 1:6
Phase 4:2
Not Applicable:1

Drug Approvals

27

NMPA:17
SFDA:6
CIMA_AEMPS:4

Drug Approvals

Oxaliplatin for Injection

Product Name
乐沙定
Approval Number
国药准字HJ20171064
Approval Date
Dec 11, 2023
NMPA

Oxaliplatin for Injection

Product Name
乐沙定
Approval Number
国药准字HJ20171065
Approval Date
Dec 11, 2023
NMPA

Sodium Valproate Sustained-release Tablets(Ⅰ)

Product Name
德巴金
Approval Number
国药准字HJ20171272
Approval Date
Jun 8, 2021
NMPA

Oxaliplatin for Injection

Product Name
乐沙定
Approval Number
国药准字J20150117
Approval Date
Jun 13, 2020
NMPA

Enoxaparin Sodium Injection

Product Name
克赛
Approval Number
国药准字J20180035
Approval Date
Feb 24, 2020
NMPA

Enoxaparin Sodium Injection

Product Name
克赛
Approval Number
国药准字J20180036
Approval Date
Feb 24, 2020
NMPA

Oxaliplatin for Injection

Product Name
乐沙定
Approval Number
H20171065
Approval Date
Dec 24, 2019
NMPA

Oxaliplatin for Injection

Product Name
乐沙定
Approval Number
H20171064
Approval Date
Dec 24, 2019
NMPA

Zopiclone Tablets

Product Name
忆孟返
Approval Number
国药准字J20140143
Approval Date
Aug 14, 2019
NMPA

Zopiclone Tablets

Product Name
忆孟返
Approval Number
H20170183
Approval Date
Jun 10, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (66.7%)
Phase 4
2 (22.2%)
Not Applicable
1 (11.1%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.